CYP19A1 and Alzheimer disease: Indeed, CYP19 gene variants could potentially affect the risk for AD by reducing or increasing the conversion of androgens into estrogens, resulting in altered protection against neuronal injury or neurodegeneration through multiple mechanisms [108].